Lidocaine Hcl Injection, Solution
Product Images NDC 51662-1538

12 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lidocaine Hcl (NDC 51662-1538). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description Table (Description Table)

Description Table (Description Table)
A data table showing the concentrations of lidocaine HCl (anhydrous) and sodium chloride in mg/mL for four different lidocaine HCl solution strengths: 0.5%, 1%, 1.5%, and 2%. The table lists lidocaine HCl values as 5, 10, 15, and 20 mg/mL and sodium chloride values as 8, 7, 6.5, and 6 mg/mL respectively.*
FDA Label Image

Structure (Description Structure)

Structure (Description Structure)
Chemical structure of lidocaine hydrochloride monohydrate, showing a benzene ring with two methyl groups and an amide side chain bonded to an amino diethyl group, associated with hydrochloride and water molecules.*
FDA Label Image

Precautions (Precautions Table)

Precautions (Precautions Table)
Table listing classes of drugs and examples associated with methemoglobinemia. Classes include Nitrates/Nitrites with examples like nitric oxide and nitroglycerin; Local anesthetics including lidocaine and bupivacaine; Antineoplastic agents such as cyclophosphamide and ifosfamide; Antibiotics including dapsone and sulfonamides; Antimalarials like chloroquine; Anticonvulsants including phenobarbital and phenytoin; and Other drugs like acetaminophen and metoclopramide.*
FDA Label Image

Dosage 1 (D And A 1)

Dosage 1 (D And A 1)
A table presenting available packaging options for Lidocaine HCl injection solution, showing three concentration strengths: 1% in 30 mL single-dose teartop vials, 1.5% in 20 mL single-dose ampuls, and 2% in 10 mL single-dose ampuls.*
FDA Label Image

Dosage 2 (D And A 2)

Dosage 2 (D And A 2)
A table titled 'Recommended Dosages' for Lidocaine Hydrochloride Injection, USP (without Epinephrine). It lists procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks, showing concentration percentages, volume ranges in mL, and total dose ranges in mg for each procedure. It includes dosing details for specific blocks like brachial, dental, thoracic, lumbar, and surgical anesthesia.*
FDA Label Image
FDA Label Image

Vial Label (Vial Label)

Vial Label (Vial Label)
Label for Lidocaine HCl Injection, USP 1% solution, 300 mg/30 mL (10 mg/mL), preservative-free, single-dose vial, 30 mL. The label states it is for infiltration and nerve block, including epidural and caudal. Distributed by Hospira, Inc., Lake Forest, IL. Contains lot and expiration date placeholders and the Hospira logo.*
FDA Label Image

Rfid Label (51662 1538 1 Rfid Label)

Rfid Label (51662 1538 1 Rfid Label)
A close-up image of a LIDOCAINE HCl injection solution label featuring barcode data, including GTIN and lot information. The label indicates it is distributed by HF Acquisitions Co., LLC, Mukilteo, WA 98275. The label displays a Data Matrix barcode and text advising to see the manufacturer's insert. The visible text includes placeholders and lot number HF1234TESTING.*
FDA Label Image

Pouch Labeling (51662 1538 2 Pouch)

Pouch Labeling (51662 1538 2 Pouch)
Label for LIDOCAINE HCl Injection, USP 1%, 10 mg/mL, 30 mL vial. The label displays the product NDC 51662-1538-2, lot number 123456, and expiration date 2030-01-01. The label indicates use for infiltration and nerve block including epidural and caudal, with preservative-free, sterile solution. Manufactured by HF Acquisition Co LLC, Mukilteo, WA.*
FDA Label Image

Vial Label (51662 1538 2 Vial)

Vial Label (51662 1538 2 Vial)
Label for Lidocaine HCl Injection USP 1% preservative-free solution, 300 mg per 30 mL vial (10 mg/mL). The label indicates single-dose 30 mL vial, for infiltration and nerve block including epidural and caudal use. Distributed by Hospira, Inc., with storage instructions and sterilization status noted.*
FDA Label Image

Case Labeling (51662 1538 3 Case)

Case Labeling (51662 1538 3 Case)
Label for LIDOCAINE HCl Injection, USP 1% (10 mg/mL) in a 30 mL vial, packaged as a case of 25. The label includes the NDC number 51662-1538-3, lot number, and expiration date. It indicates the solution is preservative-free, sterile, and nonpyrogenic, intended for infiltration and nerve block administration.*
FDA Label Image

Rfid Label (51662 1538 3 Rfid)

Rfid Label (51662 1538 3 Rfid)
Label on a packaging for LIDOCAINE HCl injection, solution, showing the serialized numeric and alphanumeric codes, a Data Matrix barcode, and text advising to see the manufacturer's insert. The label also includes distributor information: HF Acquisitions Co, LLC, Mukilteo, WA 98275.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.